Literature DB >> 22233441

Increased nitric oxide and vascular endothelial growth factor levels in the aqueous humor of patients with coats' disease.

Han Zhang1, Zhe-Li Liu.   

Abstract

PURPOSE: To determine the aqueous humor levels of nitric oxide (NO) and vascular endothelial growth factor (VEGF) in the eyes of patients with Coats' disease and study the correlation between these levels.
METHODS: Samples of aqueous humor were obtained from 7 patients with Coats' disease and 15 age-matched patients with congenital cataracts as controls. Nitrite and nitrate (NOx), the stable end products of NO, were detected by the Griess reaction, and VEGF levels were assessed by enzyme-linked immunosorbent assay.
RESULTS: The aqueous humor NOx and VEGF levels were elevated in the eyes of patients with Coats' disease compared with those of controls (P=0.001 and P<0.001, respectively). The median NOx level was 55.2 μM (range, 23.0-75.3 μM) in the Coats' disease group and 18.8 μM (range, 8.7-36.2 μM) in the control group. The median VEGF level was 731.7 pg/mL (range, 288.3-1364.3 pg/mL) in the Coats' disease group and 33.3 pg/mL (range, 9.0-96.8 pg/mL) in the control group. No correlation was observed between the aqueous humor concentrations of NOx and VEGF.
CONCLUSIONS: NOx and VEGF are increased but not related in the aqueous humor samples of patients with Coats' disease. NO and VEGF may play roles in the pathogenesis of Coats' disease. Further studies are needed to clearly elucidate the relationship among VEGF, NO, and other cytokines in Coats' disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22233441     DOI: 10.1089/jop.2011.0168

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  4 in total

1.  The effect of intravitreal bevacizumab injection as the initial treatment for Coats' disease.

Authors:  Xiao-Xue Zheng; Yan-Rong Jiang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-07-20       Impact factor: 3.117

2.  iTRAQ-Based Proteomics Investigation of Aqueous Humor from Patients with Coats' Disease.

Authors:  Qiong Yang; Hai Lu; Xudong Song; Songfeng Li; Wenbin Wei
Journal:  PLoS One       Date:  2016-07-14       Impact factor: 3.240

3.  EFFICACY OF INTRAVITREAL AFLIBERCEPT IN MACULAR TELANGIECTASIA TYPE 1 IS LINKED TO THE OCULAR ANGIOGENIC PROFILE.

Authors:  Laura Kowalczuk; Alexandre Matet; Ali Dirani; Alejandra Daruich; Aude Ambresin; Irmela Mantel; Richard F Spaide; Natacha Turck; Francine Behar-Cohen
Journal:  Retina       Date:  2017-12       Impact factor: 4.256

4.  The effects of a treatment combination of anti-VEGF injections, laser coagulation and cryotherapy on patients with type 3 Coat's disease.

Authors:  Songfeng Li; Guangda Deng; Jinghua Liu; Yan Ma; Hai Lu
Journal:  BMC Ophthalmol       Date:  2017-05-22       Impact factor: 2.209

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.